{'fraction_non_alphanumeric': 0.022702702702702703, 'fraction_numerical': 0.023783783783783784, 'mean_word_length': 5.430555555555555, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 2, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Antiretroviral drugs in development. A report from HIV DART 2008: Frontiers in Drug Development for Antiretroviral Therapies, 9-12 December 2008, Rio Grande, Puerto Rico.

HIV DART 2008, Frontiers in Drug Development for Antiretroviral Therapies, was held on 9-12 December 2008 in Puerto Rico. The stated purpose of this biannual international meeting is to assemble clinicians, researchers and basic scientists together to advance the knowledge of the ongoing drug development processes in antiretroviral research. However, there were also presentations of thematic reviews of clinical topics such as prevention and drug resistance; HIV therapy in developing countries; and HIV/hepatitis and other coinfections. This report focuses on the main theme of the conference, the antiretroviral drug development pipeline. The author is solely responsible for the selection of topics and presentations to be included in this report.